| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 10, 2004
Accepted on March 4, 2005
Departments of Obstetrics, Gynecology and Reproductive Sciences, and of Cell Biology and Physiology, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh PA
* To whom correspondence should be addressed. E-mail: rsikpc{at}mwri.magee.edu.
The endothelial ETB receptor subtype is critical for renal vasodilation induced by relaxin in nonpregnant rats and during pregnancy (the latter via endogenous circulating relaxin). Here, we tested whether expression of vascular endothelin B (ETB) receptor protein is regulated by relaxin. Small renal arteries were harvested from virgin and midterm pregnant rats, as well as from nonpregnant rats that were administered recombinant human relaxin (rhRLX) at 4 µg/h or vehicle for 5 days or for 4-6 h. Small renal arteries dissected from additional virgin rats were incubated in vitro with rhRLX or vehicle for 3 h at 37°C. ETB expression was also evaluated in cultured human endothelial cells: aortic (HAEC), coronary (HCAEC), umbilical vein (HUVEC), and dermal microvascular endothelial cells (HMVEC). Cells were incubated for 4, 8, or 24 h with rhRLX (5, 1, or 0.1ng/ml) or with vehicle. ETB protein expression in arteries and cells was evaluated by Western analysis. No regulation of ETB expression was observed in small renal arteries in any of the experimental protocols. Nor was there an increase in the vasorelaxation response to ET-3 in small renal arteries incubated in vitro with rhRLX. rhRLX only sporadically altered ETB expression in HCAEC and HUVEC at certain time points or doses, and no regulation was observed in HAEC or HMVEC. These results suggest that regulation of ETB receptor protein has little or no role in relaxin stimulation of the endothelial ETB/NO vasodilatory pathway.
This article has been cited by other articles:
![]() |
A. Jeyabalan, J. Novak, K. D. Doty, J. Matthews, M. C. Fisher, L. J. Kerchner, and K. P. Conrad Vascular Matrix Metalloproteinase-9 Mediates the Inhibition of Myogenic Reactivity in Small Arteries Isolated from Rats after Short-Term Administration of Relaxin Endocrinology, January 1, 2007; 148(1): 189 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeyabalan, L. J. Kerchner, M. C. Fisher, J. T. McGuane, K. D. Doty, and K. P. Conrad Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats J Appl Physiol, June 1, 2006; 100(6): 1955 - 1963. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |